We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$6.22B
AUM Growth
+$186M
Cap. Flow
+$50.9M
Cap. Flow %
0.82%
Top 10 Hldgs %
20.46%
Holding
730
New
167
Increased
166
Reduced
151
Closed
229

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$125M
2
PEP icon
PepsiCo
PEP
+$64.4M
3
USB icon
US Bancorp
USB
+$59.8M
4
TSN icon
Tyson Foods
TSN
+$49.4M
5
TGT icon
Target
TGT
+$48.9M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$106M
2
APTV icon
Aptiv
APTV
+$34.7M
3
AGNC icon
AGNC Investment
AGNC
+$34.2M
4
NEM icon
Newmont
NEM
+$33.9M
5
GEN icon
Gen Digital
GEN
+$28.3M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.78%
2 Healthcare 13.79%
3 Financials 11.85%
4 Utilities 10.97%
5 Technology 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MITT
426
TPG Mortgage Investment Trust
MITT
$230M
$309K 0.01%
6,195
-22,142
-78% -$1.16M
SPG icon
427
Simon Property Group
SPG
$76.8B
$301K ﹤0.01%
+2,162
New +$314K
MVC
428
DELISTED
MVC Capital, Inc.
MVC
$301K ﹤0.01%
+23,083
New +$294K
GBDC icon
429
Golub Capital BDC
GBDC
$3.38B
$300K ﹤0.01%
17,677
+10
+0.1% +$173
MGA icon
430
Magna International
MGA
$18.8B
$298K ﹤0.01%
+7,200
New +$282K
AUXL
431
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$290K ﹤0.01%
15,939
-84,301
-84% -$1.52M
PBYI icon
432
Puma Biotechnology
PBYI
$406M
$288K ﹤0.01%
+5,376
New +$290K
MLAB icon
433
Mesa Laboratories
MLAB
$559M
$280K ﹤0.01%
+4,135
New +$264K
BONT
434
DELISTED
Bon-Ton Stores Inc/The
BONT
$276K ﹤0.01%
26,151
-65,882
-72% -$1.01M
LIFE
435
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
$273K ﹤0.01%
3,647
-899
-20% -$67.1K
AES icon
436
AES
AES
$10.6B
$272K ﹤0.01%
20,431
-5,389
-21% -$69.1K
CNXN icon
437
PC Connection
CNXN
$2.1B
$262K ﹤0.01%
17,390
+4,041
+30% +$64.5K
EXLS icon
438
EXL Service
EXLS
$4.66B
$257K ﹤0.01%
45,085
+5,475
+14% +$31.3K
OABC
439
DELISTED
OMNIAMERICAN BANCORP INC COM STK (TX)
OABC
$243K ﹤0.01%
+9,924
New +$233K
CASH icon
440
Pathward Financial
CASH
$1.87B
$237K ﹤0.01%
+18,735
New +$199K
BMY icon
441
Bristol-Myers Squibb
BMY
$130B
$235K ﹤0.01%
+5,079
New +$223K
RUTH
442
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$235K ﹤0.01%
+19,839
New +$243K
LXK
443
DELISTED
Lexmark Intl Inc
LXK
$233K ﹤0.01%
7,047
-42,653
-86% -$1.51M
EGL
444
DELISTED
Engility Holdings, Inc.
EGL
$232K ﹤0.01%
+7,303
New +$237K
AVA icon
445
Avista
AVA
$3.46B
$222K ﹤0.01%
+8,401
New +$230K
NWY
446
DELISTED
New York & Co Inc
NWY
$222K ﹤0.01%
+38,414
New +$224K
CRRC
447
DELISTED
COURIER CORP
CRRC
$222K ﹤0.01%
14,008
-138
-1% -$2.13K
TRI icon
448
Thomson Reuters
TRI
$45.1B
$221K ﹤0.01%
+5,429
New +$216K
PTP
449
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
$218K ﹤0.01%
+3,648
New +$214K
AZTA icon
450
Azenta
AZTA
$1.33B
$217K ﹤0.01%
+23,260
New +$223K

Similar funds

Analytic Investors's Q3 2013 Portfolio in Review

As of Q3 2013, Analytic Investors held 730 positions worth $6.22B, up 3.1% from $6.03B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Analytic Investors's Q3 2013 filing shows 167 new, 166 increased, 151 reduced and 229 closed positions. Its largest new stake was T. Rowe Price: 421,030 shares worth $30.3M. The largest sale was Amgen, an estimated $106M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Analytic Investors's largest Q3 2013 buy was T. Rowe Price: 421,030 shares worth $30.3M.
  • Analytic Investors added most to AT&T in Q3 2013, an estimated $125M increase.
  • Analytic Investors's biggest Q3 2013 reduction was Amgen, cutting an estimated $106M.
  • Analytic Investors fully exited Aptiv in Q3 2013, selling an estimated $34.7M.
  • Analytic Investors's ten largest holdings make up 20% of its $6.22B portfolio in Q3 2013.
  • Analytic Investors opened 167 new positions and closed 229 in Q3 2013.
  • Analytic Investors's portfolio value rose 3.1% quarter-over-quarter to $6.22B.

Based on Analytic Investors's 13F filing for Q3 2013, filed 12 Nov 2013.